Donna Nichols, CAO/Controller at Recro Pharma, Inc. (REPH), bought 1,200 shares at $6.66 ($8K) on 2014-05-15, disclosed to the SEC on 2014-05-15.
Open-market purchase of $8k REPH by CAO/Controller. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.